New Product Registered to Micron’s INDICATE Program -Acer Medical’s AI Diagnostic Software for Bone Mineral Density Abnormalities and Ophthalmologic Diseases-

Micron, Inc. is pleased to announce that two new products from Acer Medical Inc. (head office: Taiwan) have been added to “INDICATE Building Bridges between Therapeutics and Diagnosis,” bringing the total number registered to three from Acer Medical. This registration is expected to contribute to the development of medical care by expanding opportunities for clinical trials and research using artificial intelligence (AI) diagnostic software for abnormal bone mineral density using chest X-ray images, age-related macular degeneration (AMD), and diabetic retinopathy (DR) using fundus images.

 

New Product Registered to Micron’s INDICATE Program, Building Bridges between Therapeutics and Diagnosis
-Acer Medical’s AI Diagnostic Software for Bone Mineral Density Abnormalities and Ophthalmologic Diseases-

 

Please contact:
Micron, Inc. INDICATE Group
indicate@micron-kobe.com

 

For details about the INDICATE Program, please refer here.